Matthias Aizenberg

Ivan Kairatov is a leading biopharma expert with a deep specialization in the intersection of oncology and innovative research and development. With years of experience navigating the complexities of the drug development pipeline and cellular biotechnology, he offers a unique perspective on the

The human body possesses a remarkable yet often dormant ability to convert sedentary fat stores into active furnaces that burn calories just to generate heat. While the medical community has long understood the distinction between energy-storing white fat and energy-burning brown fat, the molecular

The digital age has transformed how individuals manage their most intimate health details, yet a recent legal filing suggests that the promise of absolute privacy might be more of a marketing strategy than a technical reality. Natural Cycles, the first company to receive FDA clearance for a digital

The traditional landscape of drug discovery has long been characterized by grueling years of manual experimentation where researchers meticulously test one compound at a time in hopes of finding a medical miracle. In a significant departure from this slow-moving heritage, a new era has arrived

The visible markers of aging like gray hair and wrinkles frequently fail to account for the hidden biological resilience that allows one person to reach a century while another fades decades sooner. While two people may share the exact same birth year, their physiological destinies often follow

Recent breakthroughs in the field of molecular physiology have revealed that the secret to a long life might not reside within our inherited genes themselves, but rather in the microscopic molecules that govern how those genes are expressed over time. Researchers at the Duke Molecular Physiology

The traditional medical model has spent decades dissecting the mechanisms of failure, yet the most profound insights into human health may actually lie in the study of those who thrive against the odds. Longevity genomics represents a fundamental shift in the landscape of precision medicine, moving

Expert Ivan Kairatov joins us to discuss the rapidly evolving landscape of health technology, specifically focusing on the safety and reliability of consumer-facing AI tools. As a biopharma expert with deep experience in research and development, Kairatov offers a unique perspective on the

The human brain relies on a vast, microscopic network of insulation to function, yet until recently, we possessed no comprehensive "atlas" of how this protective coating is distributed across the entire organ. Scientists have now shattered this limitation by developing a high-resolution,

Matthias Aizenberg and Ivan Kairatov discuss the shifting landscape of American mental health, focusing on the nearly 38 million adults now utilizing anxiety medications. As a biopharma expert with a deep background in research and development, Kairatov provides a clinical perspective on why